[ 11C]Acetate rest-stress protocol to assess myocardial perfusion and oxygen consumption reserve in a model of congestive heart failure in rats

Nuclear Medicine and Biology

Volumn 39, Issue 2, 2012, Pages 287-294

  Croteau, Etienne ^a   Gascon, Suzanne ^a   Bentourkia, M'hamed ^a   Langlois, Réjean ^a   Rousseau, Jacques A ^a   Lecomte, Roger ^a   Bénard, François ^b  

^a UNIVERSITY OF SHERBROOKE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

11C Acetate, Cardiovascular reserve; Congestive heart failure; Dobutamine; Myocardial oxygen consumption; Myocardial perfusion; Rest stress study; Small animal PET imaging

Indexed keywords

ACETIC ACID C 11; DOBUTAMINE; DOXORUBICIN; ACETIC ACID DERIVATIVE; ANTINEOPLASTIC ANTIBIOTIC; CARBON; DIAGNOSTIC AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOTOXICITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CORONARY ARTERY; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE OXYGEN CONSUMPTION; HEART MUSCLE PERFUSION; HEART RATE; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; PHARMACOLOGIC STRESS TESTING; POSITRON EMISSION TOMOGRAPHY; RAT; REST STRESS PROTOCOL; SYSTOLIC BLOOD PRESSURE; VALIDATION PROCESS; ANIMAL; CASE CONTROL STUDY; CORONARY ARTERY BLOOD FLOW; DRUG EFFECT; HEART FAILURE; METHODOLOGY; MYOCARDIAL PERFUSION IMAGING; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; PHYSIOLOGY; SCINTISCANNING; VALIDATION STUDY;

ACETATES; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CARBON RADIOISOTOPES; CASE-CONTROL STUDIES; CORONARY CIRCULATION; DOXORUBICIN; HEART FAILURE; MYOCARDIAL PERFUSION IMAGING; OXYGEN CONSUMPTION; POSITRON-EMISSION TOMOGRAPHY; RATS;

EID: 84856357025     PISSN: 09698051     EISSN: 18729614     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2011.07.010     Document Type: Article

References (39)

1. 11C]acetate in normal physiology. Eur J Nucl Med Mol Imaging 2009, 36(9):1453-1459.
2. Knuuti J., Sundell J., Naum A., Engblom E., Koistinen J., Ylitalo A., et al. Assessment of right ventricular oxidative metabolism by PET in patients with idiopathic dilated cardiomyopathy undergoing cardiac resynchronization therapy. Eur J Nucl Med Mol Imaging 2004, 31(12):1592-1598.
3. Gregory S.A., MacRae C.A., Aziz K., Sims K.B., Schmahmann J.D., Kardan A., et al. Myocardial blood flow and oxygen consumption in patients with Friedreich's ataxia prior to the onset of cardiomyopathy. Coron Artery Dis 2007, 18(1):15-22.
4. Lindner O., Vogt J., Baller D., Kammeier A., Wielepp P., Holzinger J., et al. Global and regional myocardial oxygen consumption and blood flow in severe cardiomyopathy with left bundle branch block. Eur J Heart Fail 2005, 7(2):225-230.
5. Juillard L., Lemoine S., Janier M.F., Barthez P.Y., Bonnefoi F., Laville M. Validation of renal oxidative metabolism measurement by positron-emission tomography. Hypertension 2007, 50(1):242-247.
6. 11C-acetate in rats with small-animal PET. J Nucl Med 2006, 47(3):477-485.
7. Ziegler A., Zaugg C.E., Buser P.T., Seelig J., Kunnecke B. Non-invasive measurements of myocardial carbon metabolism using in vivo 13C NMR spectroscopy. NMR Biomed 2002, 15(3):222-234.
8. Klein L.J., Visser F.C., Knaapen P., Peters J.H., Teule G.J., Visser C.A., et al. Carbon-11 acetate as a tracer of myocardial oxygen consumption. Eur J Nucl Med 2001, 28(5):651-668.
9. Taegtmeyer H., Goodwin G.W., Doenst T., Frazier O.H. Substrate metabolism as a determinant for postischemic functional recovery of the heart. Am J Cardiol 1997, 80(3A):3A-10A.
10. Brown M.A., Myears D.W., Bergmann S.R. Validity of estimates of myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography despite altered patterns of substrate utilization. J Nucl Med 1989, 30(2):187-193.
11. Brown M.A., Myears D.W., Bergmann S.R. Noninvasive assessment of canine myocardial oxidative metabolism with carbon-11 acetate and positron emission tomography. J Am Coll Cardiol 1988, 12(4):1054-1063.
12. Wallace K.B. Doxorubicin-induced cardiac mitochondrionopathy. Pharmacol Toxicol 2003, 93(3):105-115.
13. Oliveira P.J., Bjork J.A., Santos M.S., Leino R.L., Froberg M.K., Moreno A.J., et al. Carvedilol-mediated antioxidant protection against doxorubicin-induced cardiac mitochondrial toxicity. Toxicol Appl Pharmacol 2004, 200(2):159-168.
14. Lecomte R., Cadorette J., Rodrigue S., Lapointe D., Rouleau D., Bentourkia M., et al. Initial results from the Sherbrooke avalanche photodiode positron tomograph. IEEE Trans Nucl Sci 1996, 43(3):1952-1957.
15. Bergeron M., Cadorette J., Beaudoin J., Lepage M.D., Robert G., Selivanov V., et al. Performance evaluation of the LabPET APD-based digital PET scanner. IEEE Trans Nucl Sci 2009, 56(1):10-16.
16. Bergeron M., Cadorette J., Bureau-Oxton C., Beaudoin J., Tetrault M., Leroux J., et al. Performance evaluation of the LabPET12, a large axial FOV APD-based digital PET scanner. Nuclear Science Symposium Conference Record (NSS/MIC), 2009. IEEE 2009, 4017-4021.
17. 18F-fluorodeoxyglucose in brain. Eur J Nucl Med Mol Imaging 2010, 37(8):1539-1550.
18. Selivanov V.V., Lapointe D., Bentourkia M., Lecomte R. Cross-validation stopping rule for ML-EM reconstruction of dynamic PET series: effect on image quality and quantitative accuracy. IEEE Trans Nucl Sci 2001, 48(3):883-889.
19. Buck A., Wolpers H.G., Hutchins G.D., Savas V., Mangner T.J., Nguyen N., et al. Effect of carbon-11-acetate recirculation on estimates of myocardial oxygen consumption by PET. J Nucl Med 1991, 32(10):1950-1957. [see comment].
20. 13N-ammonia. IEEE Trans Nucl Sci 2002, 49(5):2322-2327.
21. Henes C.G., Bergmann S.R., Walsh M.N., Sobel B.E., Geltman E.M. Assessment of myocardial oxidative metabolic reserve with positron emission tomography and carbon-11 acetate. J Nucl Med 1989, 30(9):1489-1499.
22. Bengel F.M., Permanetter B., Ungerer M., Nekolla S., Schwaiger M. Non-invasive estimation of myocardial efficiency using positron emission tomography and carbon-11 acetate-comparison between the normal and failing human heart. Eur J Nucl Med 2000, 27(3):319-326.
23. Nelson R.R., Gobel F.L., Jorgensen C.R., Wang K., Wang Y., Taylor H.L. Hemodynamic predictors of myocardial oxygen consumption during static and dynamic exercise. Circulation 1974, 50(6):1179-1189.
24. Sun K.T., Yeatman L.A., Buxton D.B., Chen K., Johnson J.A., Huang S.C., et al. Simultaneous measurement of myocardial oxygen consumption and blood flow using [1-carbon-11]acetate. J Nucl Med 1998, 39(2):272-280.
25. Porenta G., Cherry S., Czernin J., Brunken R., Kuhle W., Hashimoto T., et al. Noninvasive determination of myocardial blood flow, oxygen consumption and efficiency in normal humans by carbon-11 acetate positron emission tomography imaging. Eur J Nucl Med 1999, 26(11):1465-1474.
26. Gropler R.J., Siegel B.A., Geltman E.M. Myocardial uptake of carbon-11-acetate as an indirect estimate of regional myocardial blood flow. J Nucl Med 1991, 32(2):245-251.
27. Lindner O., Sorensen J., Vogt J., Fricke E., Baller D., Horstkotte D., et al. Cardiac efficiency and oxygen consumption measured with 11C-acetate PET after long-term cardiac resynchronization therapy. J Nucl Med 2006, 47(3):378-383.
28. Gould K.L., Pan T., Loghin C., Johnson N.P., Sdringola S. Reducing radiation dose in rest-stress cardiac PET/CT by single poststress cine CT for attenuation correction: quantitative validation. J Nucl Med 2008, 49(5):738-745.
29. Mirpour S., Khandani A.H. Extracardiac abnormalities on rubidium-82 cardiac positron emission tomography/computed tomography. Nucl Med Commun 2011, 32(4):260-264.
30. Range F.T., Paul M., Schafers K.P., Acil T., Kies P., Hermann S., et al. Myocardial perfusion in nonischemic dilated cardiomyopathy with and without atrial fibrillation. J Nucl Med 2009, 50(3):390-396.
31. Buus N.H., Bottcher M., Jorgensen C.G., Christensen K.L., Thygesen K., Nielsen T.T., et al. Myocardial perfusion during long-term angiotensin-converting enzyme inhibition or beta-blockade in patients with essential hypertension. Hypertension 2004, 44(4):465-470.
32. Lepage M.D., Cadorette J., Leger G., Leroux J.D., Otis M., Lecomte R. High-speed PC-based list-mode data acquisition system for the Sherbrooke animal PET scanner. J Nucl Med 2001, 42(5):204.
33. Billinger M., Raeber L., Seiler C., Windecker S., Meier B., Hess O.M. Coronary collateral perfusion in patients with coronary artery disease: effect of metoprolol. Eur Heart J 2004, 25(7):565-570. [see comment].
34. Sakanashi M., Tomomatsu E., Takeo S., Araki H., Iwasaki K., Sakamoto K., et al. Effects of dobutamine on coronary circulation and cardiac metabolism of the dog. Arzneimittelforschung 1978, 28(5):798-801.
35. Ablad B., Borg K.O., Carlsson E., Ek L., Johnson G., Malmfors T., et al. A survey of the pharmacological properties of metoprolol in animals and man. Acta Pharmacol Toxicol (Copenh) 1975, 36(Suppl 5):7-23.
36. Hodgson D.S., Dunlop C.I., Chapman P.L., Grandy J.L. Cardiopulmonary effects of anesthesia induced and maintained with isoflurane in cats. Am J Vet Res 1998, 59(2):182-185.
37. Fizanne L., Fromy B., Preckel M.P., Sigaudo-Roussel D., Saumet J.L. Effect of isoflurane on skin-pressure-induced vasodilation. J Vasc Res 2003, 40(4):416-422.
38. 13N-ammonia and small animal PET: impact of anesthesia and pharmacologic stress agents. J Nucl Med 2004, 45(11):1924-1930.
39. Mukhopadhyay P., Rajesh M., Batkai S., Kashiwaya Y., Hasko G., Liaudet L., et al. Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro. Am J Physiol Heart Circ Physiol 2009, 296(5):H1466-H1483.